Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B

research

Partnership Will Conduct Scientific Clinical Trials On ADHD; Distribute Approved European Dermal Products ISRAEL:  Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of Read the full article…

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.

WASHINGTON: The United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.  These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies. Read the full article…